1887

Chapter 10 : Serologic Diagnosis of O1 Infections

Authors: Timothy J. Barrett1, John C. Feeley1
VIEW AFFILIATIONS HIDE AFFILIATIONS
Affiliations: 1: Foodborne and Diarrheal Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333
Content Type: Monograph
Publication Year: 1994

Category: Clinical Microbiology; Bacterial Pathogenesis

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Preview Magnify
Zoom in
Zoomout

Serologic Diagnosis of O1 Infections, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818364/9781555810672_Chap10-1.gif /docserver/preview/fulltext/10.1128/9781555818364/9781555810672_Chap10-2.gif

Abstract:

Isolation of 01 from the stools of persons with diarrheal illness remains the definitive diagnostic method for cholera. The most commonly performed methods for serodiagnosis of O1 infection involve measurement of antibacterial antibodies by agglutination or vibriocidal antibody essays. A variety of methods have been used to measure the antibacterial immune responses of humans to infection with . The vibriocidal antibody test has been used extensively for serologic surveys, since it is amenable to the titration of large numbers of sera by microtiter methodology, and the acquisition of antibody through natural exposure or vaccination shows an apparent correlation to immunity on a population basis and in volunteers challenged with the organism. Other procedures such as the indirect hemagglutination test and enzyme-linked immunosorbent assays (ELISAs) have been investigated by a number of workers. While O antibodies are clearly reactive in the vibriocidal test, it is possible that other antigens such as outer membrane proteins and cell-bound hemagglutinins participate in the vibriocidal reaction. The development of cell culture models for detecting cholera toxin (CT) also provided marked improvement in the ability to measure antitoxic antibodies.

Citation: Barrett T, Feeley J. 1994. Serologic Diagnosis of O1 Infections, p 135-141. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch10

Key Concept Ranking

Outer Membrane Proteins
0.50483006
Enzyme-Linked Immunosorbent Assay
0.44330847
Infectious Diseases
0.43923151
O Antigen Lipopolysaccharide
0.42505822
0.50483006
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555818364.chap10
1. Barua, D., 1974. Laboratory diagnosis of cholera, p. 85– 126. In D. Barua, and W. Burrows (ed.), Cholera. The W. B. Saunders Co., Philadelphia.
2. Barua, D.,, and R. B. Sack. 1964. Serological studies in cholera. Indian J. Med. Res. 52: 855– 866.
3. Benenson, A. S.,, A. Saad,, and W. H. Mosley. 1968. Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique. Bull. W.H.O. 38: 277– 285.
4. Benenson, A. S.,, A. Saad,, W. H. Mosley,, and A. Ahmed. 1968. Serological studies in cholera. 3. Serum toxin neutralization—rise in titre in response to infection with Vibrio cholerae, and the level in the “normal” population of East Pakistan. Bull. W.H.O. 38: 287– 295.
5. Benenson, A. S.,, A. Saad,, and M. Paul. 1968. Serological studies in cholera. 1. Vibrio agglutinin response of cholera patients determined by a microtechnique. Bull. W.H.O. 38: 267– 276.
6. Beran, G. W. 1964. Serological studies on cholera. 1. Antibody levels observed in vaccinated and convalescent persons. Am. J. Trop. Med. Hyg. 13: 698– 707.
7. Bhattacharya, E. K.,, and S. Mukerjee. 1974. Serological analysis of the flagellar or H agglutinating antigens of cholera and NAG vibrios. Ann. Microbiol. ( Paris) 125A: 167– 181.
8. Clements, J. D.,, and R. A. Finkelstein. 1978. Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin. Infect. Immun. 21: 1036– 1039.
9. Clements, M. L.,, M. M. Levine,, C. R. Young,, R. E. Black,, Y. L. Lim,, R. M. Robins-Browne,, and J. R Craig. 1982. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. J. Infect. Dis. 145: 465– 473.
10. Craig, J. P., 1971. Cholera toxins, p. 189– 254. In S. Kadis,, T. C. Montie,, and S. J. Ajl (ed.), Microbial Toxins, vol. IIA. Academic Press, Inc., New York.
11. Donta, S. T.,, and D. M. Smith. 1974. Stimulation of steroidogenesis in tissue culture by enterotoxigenic Escherichia coli and its neutralization by specific antiserum. Infect. Immun. 9: 500– 505.
12. Feeley, J. C., 1965. Comparison of vibriocidal and agglutinating antibody responses in cholera patients, p. 220– 222. In D. A. Bushell, and C. S. Brookhyer (ed.), Proceedings of the Cholera Research Symposium, U.S. Public Health Service Publication no. 1328.
13. Finkelstein, R. A. 1962. Vibriocidal antibody inhibition (VAT) analysis: a technique for the identification of the predominant vibriocidal antibodies in serum and for the detection and identification of Vibrio cholerae antigens. J. Immunol. 89: 264– 271.
14. Finkelstein, R. A.,, and P. Atthasampunna. 1967. Immunity against experimental cholera. Proc. Soc. Exp. Biol. Med. 125: 465– 469.
15. Gallut, J.,, and G. Brounst. 1949. Sur la mise en evidence des agglutines choleriques. Ann. Inst. Pasteur (Paris) 76: 557– 559.
16. Goodner, K.,, H. L. Smith, Jr.,, and H. Stempen. 1960. Serologic diagnosis of cholera. J. Albert Einstein Med. Cent. 8: 143– 147.
17. Guerrant, R. L.,, L. L. Brunton,, T. C. Schnaitman,, L. I. Rebhun,, and A. G. Gilman. 1974. Cyclic adenosine monophosphate and alteration of Chinese hamster ovary cell morphology: a rapid, sensitive in vitro assay for the enterotoxins of Vibrio cholerae and Escherichia coli. Infect. Immun. 10: 320– 327.
18. Harris, J. R.,, S. D. Holmberg,, R. D. R. Parker,, D. E. Kay,, T. J. Barrett,, C. R. Young,, M. M. Levine,, and P. A. Blake. 1986. Impact of epidemic cholera in a previously uninfected island population: evaluation of a new seroepidemiologic method. Am. J. Epidemiol. 123: 424– 430.
19.Heiberg, B. 1935. On the Classification of Vibrio cholerae and the Cholera-Like Vibrios. Nyt Nordisk Forlag-Arnold Busck, Copenhagen.
20. Hochstein, H. D.,, J. C. Feeley,, and W. E. De-Witt. 1970. Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes. Appl. Microbiol. 19: 742– 745.
21. Holmgren, J.,, and A. M. Svennerholm. 1973. Enzyme-linked immunosorbent assays for cholera serology. Infect. Immun. 7: 759– 763.
22. Holmgren, J.,, and A. M. Svennerholm. 1974. Mechanisms of disease and immunity in cholera: a review. J. Infect. Dis. 136( Suppl.): S105– S112.
23. Kasai, G. J.,, and W. Burrows. 1966. The titration of cholera toxin and antitoxin in the rabbit ileal loop. J. Infect. Dis. 116: 606– 614.
24. Levine, M. M.,, C. R. Young,, T. P. Hughes,, S. O'Donnell,, R. B. Black,, M. L. Clements,, R. Robins-Browne,, and Y.-L. Lim. 1981. Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology. Am. J. Epidemiol. 114: 348– 354.
25. McIntyre, O. R.,, and J. C. Feeley. 1964. Passive serum protection of the infant rabbit against experimental cholera. J. Infect. Dis. 114: 468– 475.
26. Neter, E. 1956. Bacterial hemagglutination and hemolysis. Bacteriol. Rev. 20: 166– 188.
27. Pal, S. C., 1992. Laboratory diagnosis, p. 229– 251. In D. Barua, and W. B. Greenough III (Ed.), Cholera. Plenum Publishing Corp., New York.
28. Pierce, N. E.,, J. G. Banwell,, R. B. Sack,, R. C. Mitra,, and A. Mondal. 1970. Magnitude and duration of antitoxic response to human infection with Vibrio cholerae. J. Infect. Dis. 121( Suppl.): S31– S35.
29. Pollitzer, R. 1959. Cholera, p. 266– 270. W.H.O. Monograph no. 43. World Health Organization, Geneva.
30. Richardson, K. L.,, and S. D. Douglas. 1978. Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins in eucaryotic cells. Microbiol. Rev. 42: 592– 613.
31. Sack, R. B. 1975. Human diarrheal disease caused by enterotoxigenic Escherichia coli. Annu. Rev. Microbiol. 29: 333– 353.
32. Sack, R. B.,, D. Barua,, R. Saxena,, and C. C. J. Carpenter. 1966. Vibriocidal and agglutinating antibody patterns in cholera patients. J. Infect. Dis. 116: 630– 640.
33. Sakazaki, R.,, K. Tamura,, C. Z. Gomez,, and R. Sen. 1970. Serological studies on the cholera group of vibrios. Jpn. J. Med. Sci. Biol. 23: 13– 20.
34. Smith, H. L., Jr.,, and K. Goodner,. 1965. Antibody patterns in cholera, p. 215– 219. In O. A. Bushnell, and C. S. Brookhyer (ed.), Proceedings of the Cholera Research Symposium. U.S. Public Health Service Publication no. 1328. U.S. Government Printing Office, Washington, D.C.
35. Snyder, J. D.,, D. T. Allegra,, M. M. Levine,, J. P. Craig,, J. C. Feeley,, W. E. DeWitt,, and P. A. Blake. 1981. Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States. J. Infect. Dis. 143: 182– 187.
36. Svennerholm, A. M.,, and J. Holmgren. 1978. Identification of Escherichia coli heat-labile enterotoxin by means of a ganglioside immunosorbent assay (GMj-ELISA) procedure. Curr. Microbiol. 1: 19– 23.
37. Svennerholm, A.-M.,, J. Holmgren,, R. Black,, M. Levine,, and M. Merson. 1983. Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J. Infect Dis. 147: 514– 522.
38. Vella, E. E.,, and P. Fielding. 1963. Note on the agglutinability of cholera suspensions. Trans. R. Soc. Trop. Med. Hyg. 57: 112– 114.
39. Wachsmuth, I. K.,, J. C. Feeley,, W. E. DeWitt,, and C. R. Young,. 1980. Immune response to Vibrio cholerae, p. 464– 473. In N. R. Rose, and H. Friedman (ed.), Manual of Clinical Immunology, 2nd ed. American Society for Microbiology, Washington, D.C.
40. Young, C. R.,, M. M. Levine,, J. P. Craig,, and R. Robins-Browne. 1980. Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: method and correlation with rabbit skin vascular permeability factor technique. Infect. Immun. 27: 492– 496.
41. Young, C. R.,, I. K. Wachsmuth,, Ø. Olsvik,, and J. C. Feeley,. 1986. Immune response to Vibrio cholerae, p. 363– 370. In N. R. Rose,, H. Friedman,, and J. L. Fahey (ed.), Manual of Clinical Immunology, 3rd ed. American Society for Microbiology, Washington, D.C.

Back to top
This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error